Mode
Text Size
Log in / Sign up

Pulmonary lymphangitic carcinomatosis may mimic interstitial lung disease in patients with gastric adenocarcinomaLung cancer can mimic common lung diseases in young men

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Recognize that pulmonary lymphangitic carcinomatosis can mimic interstitial lung disease in patients with gastric adenocarcinoma.

This publication is a case report and review of the literature focusing on a 33-year-old male diagnosed with gastric adenocarcinoma and pulmonary lymphangitic carcinomatosis (PLC). The report details a clinical course where the patient received first-line and second-line chemotherapy, resulting in a transient improvement followed by rapid progression. The reported overall survival was approximately 6 months from the time of metastatic diagnosis.

The authors highlight that PLC can clinically mimic interstitial lung disease (ILD). They suggest that the presence of ILD-like imaging and low-energy fractures may serve as clinical indicators to prompt more specific diagnostic investigations. The review notes that EBUS-TBNA and PET-CT may facilitate timely diagnosis in these specific clinical presentations.

A significant limitation of this evidence is the small sample size, as it is based on a single case report. The findings are not representative of a broad population. Clinical application is currently limited to identifying potential diagnostic pitfalls in patients presenting with pulmonary symptoms and gastric malignancy.

How this fits prior evidence

This case report addresses a gap in the clinical presentation of gastric adenocarcinoma. While prior coverage noted that CLDN18.2 expression is found in 33.99% of patients and H. pylori prevalence is 34.3% in French Guiana, this report focuses on the pulmonary complications of the primary malignancy. It specifically highlights how pulmonary lymphangitic carcinomatosis can mimic interstitial lung disease, potentially complicating the initial diagnostic workup for patients with gastric adenocarcinoma.

Imagine feeling short of breath and thinking you have a common lung condition, only to find out it is actually a rare form of cancer. This is what happened to a 33-year-old man who was diagnosed with a rare condition called pulmonary lymphangitic carcinomatosis. This condition can look very similar to other lung diseases, making it hard for doctors to tell the difference at first glance.

The man received both first-line and second-line chemotherapy treatments. While his condition showed a brief improvement, it quickly progressed. He lived for about six months after his cancer was found to have spread. Because his condition looked like a common lung disease, it highlights how tricky these cases can be to identify early.

This case is just one example, and because it is a single case report, we cannot use it to make broad rules for everyone. However, it shows why specific tools like PET-CT scans and certain needle biopsies are helpful. These tests can help doctors spot the difference between a common lung issue and a rare cancer more quickly.

What this means for you:
A rare lung cancer can mimic common lung diseases, making early diagnosis a challenge for doctors.

Common questions

Why is it hard to diagnose this specific lung condition?

The condition, called pulmonary lymphangitic carcinomatosis, can look very similar to common lung diseases. Because the images look so much alike, doctors may need specific tools like PET-CT scans or needle biopsies to tell the difference and ensure the patient gets the right treatment quickly.

How did the patient respond to chemotherapy?

The 33-year-old man received both first-line and second-line chemotherapy. While his condition showed a transient improvement, it was followed by a rapid progression. He survived for approximately 6 months after his cancer was found to have spread.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
Pulmonary lymphangitic carcinomatosis (PLC) clinically and radiologically mimics interstitial lung disease (ILD), posing diagnostic challenges when the primary malignancy is occult. A 33-year-old male presented with progressive cough, dyspnea, and a rib fracture following minimal trauma. Chest CT showed bilateral interlobular septal thickening and mediastinal lymphadenopathy. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) of subcarinal nodes confirmed metastatic adenocarcinoma, with immunohistochemistry (CK7+,TTF-1−, Napsin A−) suggesting gastrointestinal origin. Subsequent PET-CT and gastroscopy identified a 4.0 cm gastric angulus tumor, biopsied as moderately to poorly differentiated adenocarcinoma with signet-ring cells. Despite first-line and second-line chemotherapy with transient improvement, rapid progression ensued. The patient died on February 18, 2025, with an overall survival of approximately 6 months from metastatic diagnosis. This case illustrates that in young patients with ILD-like imaging and low-energy fractures, PLC warrants consideration even without gastrointestinal symptoms. Early use of EBUS-TBNA and PET-CT may facilitate timely diagnosis in appropriate clinical settings. Signet-ring cell-associated PLC carries a dismal prognosis, and transient responses should not be misconstrued as long-term benefit.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.